Skip to the page

Data / Medical devices / United States / Calyxo, Inc.

Calyxo, Inc.: FDA-registered device maker in Pleasanton, CA, United States, 1 510(k) clearance

Calyxo, Inc. is registered with the FDA (registration 3014683069) in Pleasanton, CA, United States. It lists 2 device types. The FDA files 1 510(k) clearance under its listings, the newest dated February 2, 2024. 1 recall event names it as the recalling firm (1 Class I). Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3014683069
Address
4473 Willow Road Suite 100, Pleasanton, CA, United States, 94588
Owner or operator
Calyxo, Inc. (10058093)
Roles
Manufacturer
First device listed
February 15, 2024
Registered through
2026
Brand names listed
CVAC Aspiration System (CVAC 2.1, K261447), CVAC Aspiration System and CVAC Image Processor (K233472), CVAC Image Processor (K233472), CVAC Image Processor (SW 1.5, K260013)

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
February 2, 2024K233472CVAC Aspiration System + CVAC Image ProcessorFEDSubstantially EquivalentCalyxo, Inc.accessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
February 19, 202596340Class IOngoingCVAC Aspiration System, REF: CVC127020-1, and User Manual L00018. Intended for endoscopic examination/treatment of urinary tract and kidney interior.Aspiration system, for endoscopic examination/treatment of urinary tract and kidney interior, to have labeling update adding additional instructions, for patients with high viscosity fluid in the kidney, not to continue providing fluid inflow in the presence of unresolved slow or absent fluid outflow because this can create intrarenal pressure imbalance, andaccessdata.fda.gov

Compare with other makers

Updated March 21, 2025. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.